The increasing interest of pharmaceutical companies in the results of genetic studies of human population groups is already raising intense debate over the 'ownership' of genetic information. Few expect to find easy solutions.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Dickson, D. Whose genes are they anyway?. Nature 381, 12–13 (1996). https://doi.org/10.1038/381011a0
Issue Date:
DOI: https://doi.org/10.1038/381011a0